Astellas Pharma, Inc. (ALPMF)
12.90
+0.68
(+5.52%)
USD |
OTCM |
Dec 09, 09:40
Astellas Pharma Price: 12.90 for Dec. 9, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 14.30 |
| Nxera Pharma Co., Ltd. | 5.19 |
| PeptiDream Inc. | 12.19 |
| Stemcell Holdings, Inc. | 0.06 |
Price Related Metrics
| PE Ratio | 26.96 |
| PS Ratio | 1.719 |
| PEG Ratio | 0.1899 |
| Price to Book Value | 2.116 |
| Price to Free Cash Flow | 10.16 |
| Earnings Yield | 3.71% |
| Market Cap | 23.11B |
| PEGY Ratio | 0.1845 |
| Operating PE Ratio | 9.572 |
| Normalized PE Ratio | 26.96 |